These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 21367921
1. Gender difference in antidiuretic response to desmopressin. Juul KV, Klein BM, Sandström R, Erichsen L, Nørgaard JP. Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921 [Abstract] [Full Text] [Related]
2. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. Yamaguchi O, Nishizawa O, Juul KV, Nørgaard JP. BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147 [Abstract] [Full Text] [Related]
3. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia. Juul KV, Malmberg A, van der Meulen E, Walle JV, Nørgaard JP. BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898 [Abstract] [Full Text] [Related]
4. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP. Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773 [Abstract] [Full Text] [Related]
5. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Weiss JP, Herschorn S, Albei CD, van der Meulen EA. J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402 [Abstract] [Full Text] [Related]
6. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. Bae JH, Oh MM, Shim KS, Cheon J, Lee JG, Kim JJ, Moon DG. J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799 [Abstract] [Full Text] [Related]
7. [Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?]. ten Doesschate T, Reichert LJ, Claassen JA. Tijdschr Gerontol Geriatr; 2010 Dec; 41(6):256-61. PubMed ID: 21229778 [Abstract] [Full Text] [Related]
8. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Sand PK, Dmochowski RR, Reddy J, van der Meulen EA. J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404 [Abstract] [Full Text] [Related]
9. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men. Ho DR, Lin WY, Wu CF, Shee JJ, Huang YC, Chen CS. BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451 [Abstract] [Full Text] [Related]
11. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Rembratt A, Riis A, Norgaard JP. Neurourol Urodyn; 2006 Apr; 25(2):105-9. PubMed ID: 16304673 [Abstract] [Full Text] [Related]
12. The risk of hyponatremia with desmopressin use for nocturnal polyuria. Choi EY, Park JS, Kim YT, Park SY, Kim GH. Am J Nephrol; 2015 Apr; 41(3):183-90. PubMed ID: 25871541 [Abstract] [Full Text] [Related]
14. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin. Fu FG, Lavery HJ, Wu DL. Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590 [Abstract] [Full Text] [Related]
15. Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin. Hvistendahl GM, Frøkiaer J, Nielsen S, Djurhuus JC. J Urol; 2007 Dec; 178(6):2671-6. PubMed ID: 17945283 [Abstract] [Full Text] [Related]
16. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. Robson WL, Leung AK, Norgaard JP. J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054 [Abstract] [Full Text] [Related]
17. Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria. Chang YL, Lin AT, Chen KK. J Urol; 2007 Jun; 177(6):2227-9; discussion 2230. PubMed ID: 17509326 [Abstract] [Full Text] [Related]
18. Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome. Hashim H, Malmberg L, Graugaard-Jensen C, Abrams P. Neurourol Urodyn; 2009 Jun; 28(1):40-6. PubMed ID: 18726947 [Abstract] [Full Text] [Related]
19. Long-term durability of the response to desmopressin in female and male nocturia patients. Juul KV, Klein BM, Nørgaard JP. Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524 [Abstract] [Full Text] [Related]
20. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Rovner ES, Raymond K, Andruczyk E, Juul KV. Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762 [Abstract] [Full Text] [Related] Page: [Next] [New Search]